The Myth of the Perfect Study for U.S. Market Access

The Myth of the Perfect Study for U.S. Market Access

The Myth of the Perfect Study for U.S. Market AccessNicole Coustier
Published on: 12/08/2025

One study rarely unlocks full payer coverage. Learn why U.S. market access requires a portfolio of evidence, strategic sequencing, and payer-specific insights.

Evidence Planning
The Hidden Bias in Reimbursement: Why First Movers May Have It Easier

The Hidden Bias in Reimbursement: Why First Movers May Have It Easier

The Hidden Bias in Reimbursement: Why First Movers May Have It EasierNicole Coustier
Published on: 06/02/2025

Why do better technologies struggle for reimbursement while outdated ones thrive? Discover the hidden bias in payer decision-making—and why second movers in MedTech face steeper evidence hurdles than the first.

Coding and PaymentEvidence PlanningFundamentalsFeatured